SYRACUSE, N.Y., Sept. 23, 2020 /PRNewswire/ -- Quadrant Biosciences Inc., a developer of epigenetic diagnostic tools, announced today that it has received an Emergency Use Authorization (EUA) from the ...

The companies will work to integrate Prevencio's protein-based blood tests into Quadrant's care pathways to better translate the results into clinical action and measure outcomes.

HOUSTON--(BUSINESS WIRE)--Ranorex (a division of Idera, Inc.), a provider of testing automation tools, today announced it has been named a Niche Player in the 2018 Gartner Magic Quadrant for Software ...

Quadrant Biosciences said late Wednesday it received an emergency approval from the Food and Drug Administration for a saliva-based COVID-19 test. The privately held Syracuse, N.Y.-based company ...